Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.
Clinical trial NCT04073784 · UNKNOWN
Trial details
- NCT number
- NCT04073784
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-08
- Primary completion
- 2022-04-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.